sunitinib teva 50mg tvrdá tobolka
teva b.v., haarlem array - 17420 sunitinib - tvrdá tobolka - 50mg - sunitinib
sunitinib teva 12,5mg tvrdá tobolka
teva b.v., haarlem array - 17420 sunitinib - tvrdá tobolka - 12,5mg - sunitinib
sunitinib teva 25mg tvrdá tobolka
teva b.v., haarlem array - 17420 sunitinib - tvrdá tobolka - 25mg - sunitinib
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastická činidla - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib fmk 12,5mg tvrdá tobolka
farmak international sp.z.o.o., varšava array - 17420 sunitinib - tvrdá tobolka - 12,5mg - sunitinib
sunitinib fmk 25mg tvrdá tobolka
farmak international sp.z.o.o., varšava array - 17420 sunitinib - tvrdá tobolka - 25mg - sunitinib
sunitinib fmk 37,5mg tvrdá tobolka
farmak international sp.z.o.o., varšava array - 17420 sunitinib - tvrdá tobolka - 37,5mg - sunitinib
sunitinib fmk 50mg tvrdá tobolka
farmak international sp.z.o.o., varšava array - 17420 sunitinib - tvrdá tobolka - 50mg - sunitinib
sunitinib krka 12,5mg tvrdá tobolka
krka, d.d., novo mesto, novo mesto array - 17468 sunitinib-malÁt - tvrdá tobolka - 12,5mg - sunitinib
sunitinib krka 25mg tvrdá tobolka
krka, d.d., novo mesto, novo mesto array - 17468 sunitinib-malÁt - tvrdá tobolka - 25mg - sunitinib